NASDAQ:SLS
Sellas Life Sciences Group Inc (SLS)
Financials 
Technical Analysis 
Sep 2, 2026, 12:00 amThis summary was created by AI, based on 1 opinions in the last 12 months.
Sellas Life Sciences Group Inc (SLS-Q) recently reported operating expenses of $7.1 million, reflecting a minor increase of 3.1% from the previous quarter. This rise in operating expenses may indicate either inefficiencies in operations or strategic investments aimed at growth. On the profitability front, the company's net income for the quarter was reported at -$6.8 million, showing a further decline of 2.9% compared to the prior quarter; this raises some concerns regarding the financial health of the company, despite potential one-time costs or investments that may have influenced these figures. Social media buzz around Sellas has seen a positive spike, with mentions increasing by 14.4% in just the last 24 hours, potentially signaling heightened interest or speculation in the company's future prospects. Stakeholders should closely monitor these developments, balancing the operating costs with the ongoing trend in public sentiment.
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content
- «
- ‹
- 1
- ›
- »
Popular Articles
Sellas Life Sciences Group Inc (SLS) Frequently Asked Questions
What is Sellas Life Sciences Group Inc stock symbol?
Sellas Life Sciences Group Inc is a American stock, trading under the symbol SLS (previously SLS-Q on Stockchase) on the NASDAQ (SLS). It is usually referred to as NASDAQ:SLS or SLS
Is Sellas Life Sciences Group Inc a buy or a sell?
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on SLS (previously SLS-Q on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Sellas Life Sciences Group Inc.
Is Sellas Life Sciences Group Inc a good investment or a top pick?
Sellas Life Sciences Group Inc was recommended as a Top Pick by The Weekly Buzzing Stocks by Billy Kawasaki on 2026-01-08. Read the latest stock experts ratings for Sellas Life Sciences Group Inc.
Why is Sellas Life Sciences Group Inc stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Sellas Life Sciences Group Inc.
Is Sellas Life Sciences Group Inc worth watching?
Sellas Life Sciences Group Inc is covered by Stockchase experts and is worth watching.
What is Sellas Life Sciences Group Inc stock price?
On 2026-09-02, Sellas Life Sciences Group Inc (SLS) stock closed at a price of $14.16.
Operating Expenses for this period were 7.1M, showing a 3.1% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas. Net Income for the quarter was -6.8M, showing a -2.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments. Social media mentions are up 14.4% in the past 24h.